Investing.com - J&J reported on Tuesday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
J&J announced earnings per share of $1.86 on revenue of $22.48B. Analysts polled by Investing.com anticipated EPS of $1.83 on revenue of $21.69B.
J&J shares are up 5% from the beginning of the year, still down 0.05% from its 52 week high of $166.06 set on January 25. They are outperforming the S&P Global 100 which is up 3.1% from the start of the year.
J&J follows other major Healthcare sector earnings this month
J&J's report follows an earnings missed by Novartis ADR on Tuesday, who reported EPS of $1.34 on revenue of $12.77B, compared to forecasts EPS of $1.36 on revenue of $12.92B.
Intuitive Surgical had beat expectations on Thursday with fourth quarter EPS of $3.58 on revenue of $1.33B, compared to forecast for EPS of $3.12 on revenue of $1.25B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar